These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 11719447

  • 1. Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-acetylcysteine.
    Albini A, Morini M, D'Agostini F, Ferrari N, Campelli F, Arena G, Noonan DM, Pesce C, De Flora S.
    Cancer Res; 2001 Nov 15; 61(22):8171-8. PubMed ID: 11719447
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of Kaposi's sarcoma in vivo by fenretinide.
    Ferrari N, Morini M, Pfeffer U, Minghelli S, Noonan DM, Albini A.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):6020-9. PubMed ID: 14676128
    [Abstract] [Full Text] [Related]

  • 3. Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor.
    Gerber HP, Kowalski J, Sherman D, Eberhard DA, Ferrara N.
    Cancer Res; 2000 Nov 15; 60(22):6253-8. PubMed ID: 11103779
    [Abstract] [Full Text] [Related]

  • 4. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
    Deryugina EI, Soroceanu L, Strongin AY.
    Cancer Res; 2002 Jan 15; 62(2):580-8. PubMed ID: 11809713
    [Abstract] [Full Text] [Related]

  • 5. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.
    Cancer Res; 2003 Sep 15; 63(18):5978-91. PubMed ID: 14522925
    [Abstract] [Full Text] [Related]

  • 6. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
    Ciardiello F, Bianco R, Damiano V, Fontanini G, Caputo R, Pomatico G, De Placido S, Bianco AR, Mendelsohn J, Tortora G.
    Clin Cancer Res; 2000 Sep 15; 6(9):3739-47. PubMed ID: 10999768
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
    Fassina G, Venè R, Morini M, Minghelli S, Benelli R, Noonan DM, Albini A.
    Clin Cancer Res; 2004 Jul 15; 10(14):4865-73. PubMed ID: 15269163
    [Abstract] [Full Text] [Related]

  • 8. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.
    Cornali E, Zietz C, Benelli R, Weninger W, Masiello L, Breier G, Tschachler E, Albini A, Stürzl M.
    Am J Pathol; 1996 Dec 15; 149(6):1851-69. PubMed ID: 8952523
    [Abstract] [Full Text] [Related]

  • 9. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW, Karashima T, Perrotte P, Inoue K, Kim SJ, Izawa J, Kedar D, McConkey DJ, Millikan R, Sweeney P, Yoshikawa C, Shuin T, Dinney CP.
    Clin Cancer Res; 2001 Sep 15; 7(9):2840-53. PubMed ID: 11555602
    [Abstract] [Full Text] [Related]

  • 10. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
    Mallery SR, Morse MA, Wilson RF, Pei P, Ness GM, Bradburn JE, Renner RJ, Schuller DE, Robertson FM.
    J Cell Biochem; 2003 May 01; 89(1):133-43. PubMed ID: 12682914
    [Abstract] [Full Text] [Related]

  • 11. N-acetylcysteine inhibits endothelial cell invasion and angiogenesis.
    Cai T, Fassina G, Morini M, Aluigi MG, Masiello L, Fontanini G, D'Agostini F, De Flora S, Noonan DM, Albini A.
    Lab Invest; 1999 Sep 01; 79(9):1151-9. PubMed ID: 10496534
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI, Sweeney P, Perrotte P, Kedar D, Dong Z, Slaton JW, Karashima T, Inoue K, Benedict WF, Dinney CP.
    Clin Cancer Res; 2002 Apr 01; 8(4):1258-70. PubMed ID: 11948141
    [Abstract] [Full Text] [Related]

  • 13. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C, Zieher H, Roth A, Hauser K, Lipson KE, Weber KJ, Debus J, Abdollahi A, Huber PE.
    Clin Cancer Res; 2008 Apr 01; 14(7):2210-9. PubMed ID: 18381963
    [Abstract] [Full Text] [Related]

  • 14. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
    Hagedorn M, Zilberberg L, Wilting J, Canron X, Carrabba G, Giussani C, Pluderi M, Bello L, Bikfalvi A.
    Cancer Res; 2002 Dec 01; 62(23):6884-90. PubMed ID: 12460903
    [Abstract] [Full Text] [Related]

  • 15. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
    Zhang L, Yu D, Hu M, Xiong S, Lang A, Ellis LM, Pollock RE.
    Cancer Res; 2000 Jul 01; 60(13):3655-61. PubMed ID: 10910082
    [Abstract] [Full Text] [Related]

  • 16. HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma.
    Sgadari C, Barillari G, Toschi E, Carlei D, Bacigalupo I, Baccarini S, Palladino C, Leone P, Bugarini R, Malavasi L, Cafaro A, Falchi M, Valdembri D, Rezza G, Bussolino F, Monini P, Ensoli B.
    Nat Med; 2002 Mar 01; 8(3):225-32. PubMed ID: 11875492
    [Abstract] [Full Text] [Related]

  • 17. Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production.
    Zeng G, Gao L, Birklé S, Yu RK.
    Cancer Res; 2000 Dec 01; 60(23):6670-6. PubMed ID: 11118051
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101.
    Murakami K, Sakukawa R, Sano M, Hashimoto A, Shibata J, Yamada Y, Saiki I.
    Clin Cancer Res; 1999 Sep 01; 5(9):2304-10. PubMed ID: 10499597
    [Abstract] [Full Text] [Related]

  • 19. [Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway].
    Wang F, Tian YH, Li L, Chen XF, Hu HH, Li CY, Huang Q.
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar 01; 34(2):165-70. PubMed ID: 12006990
    [Abstract] [Full Text] [Related]

  • 20. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
    Hong YK, Chung DS, Joe YA, Yang YJ, Kim KM, Park YS, Yung WK, Kang JK.
    Clin Cancer Res; 2000 Aug 01; 6(8):3354-60. PubMed ID: 10955823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.